Skip to Content

TEVA 7334 (Mycophenolate mofetil 250 mg)

Pill with imprint TEVA 7334 is Blue & Orange, Capsule-shape and has been identified as Mycophenolate mofetil 250 mg. It is supplied by Teva Pharmaceuticals USA.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; systemic lupus erythematosus; pulmonary fibrosis; autoimmune hepatitis; organ transplant, rejection prophylaxis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 7334

Mycophenolate mofetil 250 mg TEVA 7334
Mycophenolate mofetil 250 mg TEVA 7334
Mycophenolate mofetil 250 mg TEVA 7334

Mycophenolate mofetil

Imprint:
TEVA 7334
Strength:
250 mg
Color:
Blue & Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide